Audentes Therapeutics: 1Q Earnings Snapshot
SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Wednesday reported a loss of $25.6 million in its first quarter.
The San Francisco-based company said it had a loss of 74 cents per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 81 cents per share.
Audentes Therapeutics shares have climbed 18 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $37, more than doubling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BOLD at https://www.zacks.